IRONMAN failed primary endpoint but shows potential long-term benefits of iron repletion in HF patients Presented ByProf. Paul Kalra, University of Glasgow, UK TrialPhase 4, IRONMAN ConferenceAHA 2022 11 January, 2023 18:05